The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants

Ido Laish*, Menachem Schechter, Alain Dancour, Sari Lieberman, Zohar Levi, Yael Goldberg, Inbal Kedar, Erez Hasnis, Elizabeth Half, Gili Reznick Levi, Lior Katz, Elez D. Vainer, Dor Genzel, Maya Aharoni, Rakefet Chen-Shtoyerman, Naim Abu-Freha, Maria Raitses-Gurevich, Talia Golan, Rinat Bernstein-Molho, Merav Ben YehoyadaNathan Gluck, Guy Rosner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology